Effects of CB1R inverse agonist, INV ‐202, in patients with features of metabolic syndrome. A randomized, placebo‐controlled, double‐blind phase 1b study

Crater, Glenn D., Lalonde, Karine, Ravenelle, François · Diabetes, Obesity and Metabolism · 2024